Deerfield Mgmt L.P.'s Net Worth
$0
Who is Deerfield Mgmt L.P.?
Deerfield Mgmt L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., Dicerna Pharmaceuticals Inc, Invuity, Inc., DYNAVAX TECHNOLOGIES CORP, XERIS PHARMACEUTICALS INC, ARENA PHARMACEUTICALS INC, Invitae Corp, Auspex Pharmaceuticals, Inc., Fibrocell Science, Inc., TriVascular Technologies, Inc., REGENXBIO Inc., CONSTELLATION PHARMACEUTICALS INC, NeurogesX Inc, DFP HEALTHCARE ACQUISITIONS CORP., Nkarta, Inc., Revolution Medicines, Inc., Kiniksa Pharmaceuticals, Ltd., DA32 Life Science Tech Acquisition Corp., RIGEL PHARMACEUTICALS INC, eHealth, Inc., Singular Genomics Systems, Inc., Nivalis Therapeutics, Inc., Deerfield Healthcare Technology Acquisitions Corp., Shockwave Medical, Inc., Aclaris Therapeutics, Inc., Vanda Pharmaceuticals Inc., Generation Bio Co., ANTARES PHARMA, INC., AERIE PHARMACEUTICALS INC, AVADEL PHARMACEUTICALS PLC, Axogen, Inc., ARVINAS INC., Neos Therapeutics, Inc., Loxo Oncology, Inc., NeuroMetrix, Inc., Mirum Pharmaceuticals, Inc., GRAYBUG VISION, INC., Acutus Medical, Inc., Xilio Therapeutics, Inc., Larimar Therapeutics, Inc., Terns Pharmaceuticals, Inc., Cyclacel Pharmaceuticals, Inc., Syros Pharmaceuticals, Inc., Recro Pharma, Inc., CATALYST BIOSCIENCES, INC., CytomX Therapeutics, Inc., Mallinckrodt plc, CAS MEDICAL SYSTEMS INC, PROTEON THERAPEUTICS INC, AveXis, Inc., SteadyMed Ltd., Cabaletta Bio, Inc., Annexon, Inc., aTYR PHARMA INC, ALIMERA SCIENCES INC, Black Diamond Therapeutics, Inc., Ignyte Acquisition Corp., Werewolf Therapeutics, Inc., STREAMLINE HEALTH SOLUTIONS INC., Frequency Therapeutics, Inc., Oncorus, Inc., Audentes Therapeutics, Inc., AUXILIUM PHARMACEUTICALS INC, Talon Therapeutics, Inc., NxStage Medical, Inc., PepGen Inc., HI TECH PHARMACAL CO INC, DUSA PHARMACEUTICALS INC, PAR PHARMACEUTICAL COMPANIES, INC., Frazier Lifesciences Acquisition Corp, Nuvalent, Inc., ANADYS PHARMACEUTICALS INC, XENOPORT INC, ISTA PHARMACEUTICALS INC, Somaxon Pharmaceuticals, Inc., SALIX PHARMACEUTICALS LTD, MEDICINES CO /DE, NITROMED INC, VIA Pharmaceuticals, Inc., EMAGEON INC, THIRD WAVE TECHNOLOGIES INC /WI, INSPIRE PHARMACEUTICALS INC, Homology Medicines, Inc., Avalanche Biotechnologies, Inc., Schrodinger, Inc., AdaptHealth Corp., and FISCHER IMAGING CORP.
SEC CIK
Deerfield Mgmt L.P.'s CIK is 0001010823
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 937.01K |
$17.00 |
—
| 937.01K |
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dicerna Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.36% | -321.96K |
$11.36 | -$3,657,513.62 | 1.77M |
Nov 21 - Nov 25
| |||
Form 4
| -100.00% | -214.16K |
$9.05 | -$1,938,354.00 |
0
|
Nov 7
| |||
Form 4
| -4.27% | -117.78K |
$11.40 | -$1,279,557.02 | 2.64M |
Oct 10 - Oct 15
| |||
Form 4
| +100.00% | 2.43M |
$15.00 | $15,000,000.00 | 4.86M |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Invuity, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.85% | -184.80K |
$6.22 | -$1,148,909.05 | 1.69M |
Dec 12 - Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $10.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.85M |
$0.25 | -$1,213,992.59 |
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
| +24.35% | 950K |
$4.40 | $4,180,000.00 | 4.85M |
Oct 4
| |||
Form 4/A
| +7.92% | 24.1K |
$5.50 | $132,542.77 | 328.45K |
May 15
| |||
Form 4
| +8.68% | 102.74K |
$5.36 | $563,171.22 | 1.29M |
May 11 - May 15
| |||
Form 4
| +1.86% | 69.2K |
$5.61 | $384,670.40 | 3.8M |
Apr 28 - May 1
| |||
Form 4/A
| +0.71% | 25.28K |
$6.02 | $152,068.00 | 3.59M |
Apr 5
| |||
Form 4
| +3.96% | 142.09K |
$5.50 | $781,795.92 | 3.73M |
Apr 20 - Apr 24
| |||
Form 4
| +3.53% | 122.48K |
$6.03 | $738,516.68 | 3.59M |
Apr 3 - Apr 5
| |||
Form 4
| +3.61% | 120.61K |
$5.97 | $720,008.39 | 3.47M |
Mar 15 - Mar 17
| |||
Form 4
| +0.99% | 32.8K |
$6.02 | $197,234.51 | 3.34M |
Mar 7 - Mar 9
| |||
Form 4
| +3.73% | 119.23K |
$5.90 | $703,600.07 | 3.31M |
Mar 3
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XERIS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.84% | -7.24K |
$15.09 | -$109,250.53 | 856.47K |
Feb 8 - Feb 11
| |||
Form 4
| -1.69% | -14.81K |
$15.02 | -$222,442.86 | 863.71K |
Feb 5 - Feb 7
| |||
Form 4
| -0.79% | -7.04K |
$15.12 | -$106,448.09 | 878.52K |
Jan 28 - Jan 29
| |||
Form 4
| -11.44% | -114.44K |
$15.43 | -$1,766,192.63 | 885.56K |
Jan 23 - Jan 25
| |||
Form 4
|
∞
| 2.5M |
$15.00 |
—
| 2.5M |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||